0001651511-19-000001.txt : 20190628 0001651511-19-000001.hdr.sgml : 20190628 20190628143348 ACCESSION NUMBER: 0001651511-19-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20190628 DATE AS OF CHANGE: 20190628 EFFECTIVENESS DATE: 20190628 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Ultivue, Inc. CENTRAL INDEX KEY: 0001651511 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-343102 FILM NUMBER: 19928876 BUSINESS ADDRESS: STREET 1: 763D CONCORD AVE. CITY: CAMBRIDGE STATE: MA ZIP: 02138 BUSINESS PHONE: 781-883-1531 MAIL ADDRESS: STREET 1: 763D CONCORD AVE. CITY: CAMBRIDGE STATE: MA ZIP: 02138 D 1 primary_doc.xml X0708 D LIVE 0001651511 Ultivue, Inc. 763D CONCORD AVE. CAMBRIDGE MA MASSACHUSETTS 02138 781-883-1531 DELAWARE None None Corporation true 2015 Michael Natan 763D Concord Ave. Cambridge MA MASSACHUSETTS 02138 Executive Officer Director Keith Crandell 763D Concord Ave. Cambridge MA MASSACHUSETTS 02138 Director Andrew Stevenson 763D Concord Ave. Cambridge MA MASSACHUSETTS 02138 Director Peng Yin 763D Concord Ave. Cambridge MA MASSACHUSETTS 02138 Director David R. Walt 763D Concord Ave. Cambridge MA MASSACHUSETTS 02138 Director Wen Chen 763D Concord Ave. Cambridge MA MASSACHUSETTS 02138 Director Lian Yong Chen 763D Concord Ave. Cambridge MA MASSACHUSETTS 02138 Director Sharon Kedar 763D Concord Ave. Cambridge MA MASSACHUSETTS 02138 Director Biotechnology Decline to Disclose 06b false 2019-06-13 false true false 0 26502993 26502993 0 Amount sold in item 13 and number of investors in item 14 includes $4,248,773 from the conversion of promissory notes. false 14 0 0 0 false Ultivue, Inc. /s/Michael Natan Michael Natan President 2019-06-28